← Back to Events

Cardiology at the interface of primary and secondary care: session 3 – How to improve heart failure outcomes

Topic:
Cardiology at the interface of primary and secondary care
Facilitated by:
Primary Health Tasmania
Speaker:
Nathan Dwyer
Date and time:
Wednesday 23 July - 6:30pm to 8:00pm
Location:
Online via Zoom
Audience:
General practitioners working in Tasmania

As part of the Cardiology at the Interface of Primary and Secondary Care webinar series, this 90-minute interactive session will focus on the role of general practitioners in the management of heart failure, a common condition with high morbidity and hospital readmission rate. There is strong evidence that comprehensive multidisciplinary care with GPs as the central cog improve heart failure outcomes.

This session will provide a practical overview to the identification and diagnosis of heart failure in the primary care setting, strategies to achieve optimal guideline directed therapy, tips for interpreting an echocardiogram, and recognising when specialist referral is appropriate.

Learning outcomes:

  1. Describe the mechanisms involved in the development of HFrEF and HFpEF
  2. Interpret evidence based diagnostic strategies for heart failure
  3. Recall a Mnemonic for the evidence based therapies for heart failure
  4. Demonstrate comfort in prescribing and titrating the 4 Pillars of heart failure therapy

Speaker Information:

Nathan is an interventional cardiologist and Director of Cardiology at the Royal Hobart Hospital. He’s an elected board member of the Cardiac Society of Australia and New Zealand. Graduating from the University of Tasmania in 2000, he completed his specialty cardiology training at the Royal Hobart Hospital in 2007. He was awarded his PhD in 2010 by researching pulmonary haemodynamics and wave reflection before undertaking 2 years of subspecialty training in coronary intervention and clinical research at the Libin Cardiovascular Institute of Alberta, Calgary, Canada. Nathan has strong clinical interests in heart failure, pulmonary hypertension, and coronary intervention. He’s actively involved in clinical trials and system redesign. In his leadership capacity he’s an advocate for civility and humility in healthcare for improved patient outcomes.